Eplontersen

Wainzua 45 MG Solucion Inyectable en Pluma Precargada

47 mg solución inyectable en pluma precargadaSpainMarketedAuthorised 12 Mar 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

WainzuaEuropean UnionAuthorised

WainzuaEuropean Union · AstraZeneca ABSame brand
WainzuaCroatiaSame brand
WainzuaItaly · Soluzione iniettabile in penna pre-riempita · Astrazeneca ABSame brand
Wainzua 45 mg oplossing voor injectie in een voorgevulde penNetherlands · Oplossing voor injectie · AstraZeneca ABSame brand
Wainua Solution for Injection in Autoinjector 45MG/0.8MLSingapore · 45mg/0.8ml · injection, solution · Astrazeneca Singapore Pte LTDSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Eplontersen

Wainzua 45 MG Solucion Inyectable en Pluma Precargada

47 mg solución inyectable en pluma precargadaSpainMarketedAuthorised 12 Mar 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

WainzuaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

WainuaBrazil · Astrazeneca do Brasil Ltda

WainuaCanada · 45 MG / 0.8 ML · Solution · Astrazeneca Canada INC

WainuaUnited States · 45MG BASE/0.8ML · solution · Astrazeneca AB

Wainua (Autoinjector)United States · 45MG BASE/0.8ML · solution · Astrazeneca AB

Packs

Pack	Code	Status
WAINZUA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,8 ml	767127

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Eplontersen
Strength: 47 mg
Dosage form: solución inyectable en pluma precargada
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 12 Mar 2025
Registration: 1241875001
Marketing authorisation holder: Astrazeneca Ab
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/24/1875